GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call

Rhea-AI Summary

GoodRx Holdings, the leading prescription savings platform in the U.S., announced the release date of its second quarter 2024 financial results. The report will be made public on Thursday, August 8, 2024, before the U.S. markets open.

On the same day, at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time), the company will hold a conference call and webcast to discuss the results and business outlook. Interested parties can pre-register for the call to receive dial-in details and a unique passcode. The live webcast and accompanying materials will be available on the company's investor relations website. An archived version of the webcast will be accessible approximately one hour after the live event and will remain available for at least 30 days.

SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced it will release its second quarter 2024 financial results before U.S. markets open on Thursday, August 8, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.

Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.

About GoodRx

GoodRx is the leading prescription savings platform in the U.S. Trusted by more than 25 million consumers and 750,000 healthcare professionals annually, GoodRx provides access to savings and affordability options for generic and brand-name medications at more than 70,000 pharmacies nationwide, as well as comprehensive healthcare research and information. Since 2011, GoodRx has helped consumers save nearly $75 billion on the cost of their prescriptions.

GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240711972987/en/

Investor Contact

ir@goodrx.com

Media Contact

press@goodrx.com

Source: GoodRx Holdings, Inc.

FAQ

When will GoodRx release its second quarter 2024 financial results?

GoodRx will release its second quarter 2024 financial results before the U.S. markets open on Thursday, August 8, 2024.

What time is the GoodRx second quarter 2024 earnings conference call?

The GoodRx second quarter 2024 earnings conference call will be held at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on August 8, 2024.

How can I access the GoodRx second quarter 2024 earnings conference call?

To access the conference call, pre-register using the provided link to receive dial-in details and a unique passcode. The call will also be webcast live on GoodRx's investor relations website.

Where can I find the archived webcast of GoodRx's second quarter 2024 earnings call?

An archived version of the webcast will be available on GoodRx's investor relations website approximately one hour after the live call and will be accessible for at least 30 days.